Influenza A |
167 |
23 |
46 |
46 |
1.78E-06 |
0.000565 |
Epstein-Barr virus infection |
201 |
27.7 |
50 |
50 |
1.51E-05 |
0.00229 |
Legionellosis |
55 |
7.58 |
20 |
20 |
2.16E-05 |
0.00229 |
Kaposi’s sarcoma-associated herpesvirus infection |
186 |
25.7 |
46 |
46 |
3.85E-05 |
0.00279 |
Hepatitis C |
155 |
21.4 |
40 |
40 |
4.38E-05 |
0.00279 |
Small cell lung cancer |
93 |
12.8 |
27 |
27 |
9.07E-05 |
0.00481 |
Bladder cancer |
41 |
5.65 |
15 |
15 |
0.000212 |
0.00877 |
Platinum drug resistance |
73 |
10.1 |
22 |
22 |
0.000221 |
0.00877 |
Complement and coagulation cascades |
79 |
10.9 |
23 |
23 |
0.000282 |
0.00996 |
TNF signaling pathway |
110 |
15.2 |
29 |
29 |
0.000324 |
0.0103 |
Measles |
138 |
19 |
34 |
34 |
0.000413 |
0.011 |
Chronic myeloid leukemia |
76 |
10.5 |
22 |
22 |
0.000415 |
0.011 |
Chemokine signaling pathway |
190 |
26.2 |
43 |
43 |
0.000556 |
0.0136 |
Pathways in cancer |
530 |
73.1 |
99 |
99 |
0.000689 |
0.0156 |
Glioma |
75 |
10.3 |
21 |
21 |
0.000902 |
0.0191 |
Apoptosis - multiple species |
33 |
4.55 |
12 |
12 |
0.000964 |
0.0192 |
Non-small cell lung cancer |
66 |
9.1 |
19 |
19 |
0.00108 |
0.0203 |
Apoptosis |
136 |
18.8 |
32 |
32 |
0.00139 |
0.0245 |
Rheumatoid arthritis |
91 |
12.5 |
23 |
23 |
0.00237 |
0.0397 |
Type II diabetes mellitus |
46 |
6.34 |
14 |
14 |
0.0027 |
0.041 |
Focal adhesion |
199 |
27.4 |
42 |
42 |
0.00271 |
0.041 |
Melanoma |
72 |
9.93 |
19 |
19 |
0.00328 |
0.0474 |
EGFR tyrosine kinase inhibitor resistance |
79 |
10.9 |
20 |
20 |
0.00435 |
0.0601 |
ErbBsignaling pathway |
85 |
11.7 |
21 |
21 |
0.0048 |
0.0636 |
Glyoxylate and dicarboxylate metabolism |
30 |
4.14 |
10 |
10 |
0.00523 |
0.0659 |
Colorectal cancer |
86 |
11.9 |
21 |
21 |
0.00555 |
0.0659 |
Prion diseases |
35 |
4.83 |
11 |
11 |
0.00574 |
0.0659 |
Central carbon metabolism in cancer |
65 |
8.96 |
17 |
17 |
0.0058 |
0.0659 |
p53 signaling pathway |
72 |
9.93 |
18 |
18 |
0.00762 |
0.0835 |
Hepatitis B |
163 |
22.5 |
34 |
34 |
0.00789 |
0.0837 |
Mismatch repair |
23 |
3.17 |
8 |
8 |
0.00918 |
0.0941 |
Insulin signaling pathway |
137 |
18.9 |
29 |
29 |
0.011 |
0.109 |
Viral myocarditis |
59 |
8.14 |
15 |
15 |
0.0121 |
0.117 |
Prolactin signaling pathway |
70 |
9.65 |
17 |
17 |
0.0126 |
0.117 |
IL-17 signaling pathway |
93 |
12.8 |
21 |
21 |
0.0139 |
0.124 |
Carbon metabolism |
116 |
16 |
25 |
25 |
0.014 |
0.124 |
Osteoclast differentiation |
128 |
17.7 |
27 |
27 |
0.0145 |
0.124 |
Endocytosis |
244 |
33.6 |
46 |
46 |
0.0153 |
0.128 |
Proteasome |
45 |
6.21 |
12 |
12 |
0.0162 |
0.132 |
Glutathione metabolism |
56 |
7.72 |
14 |
14 |
0.0174 |
0.136 |
NOD-like receptor signaling pathway |
178 |
24.5 |
35 |
35 |
0.0175 |
0.136 |
Glycolysis / Gluconeogenesis |
68 |
9.38 |
16 |
16 |
0.0204 |
0.154 |
D-Glutamine and D-glutamate metabolism |
5 |
0.69 |
3 |
3 |
0.0211 |
0.156 |
Renal cell carcinoma |
69 |
9.52 |
16 |
16 |
0.0232 |
0.168 |
Endocrine resistance |
98 |
13.5 |
21 |
21 |
0.0244 |
0.172 |
PI3K-Akt signaling pathway |
354 |
48.8 |
62 |
62 |
0.0253 |
0.175 |
Pertussis |
76 |
10.5 |
17 |
17 |
0.0275 |
0.186 |
B cell receptor signaling pathway |
71 |
9.79 |
16 |
16 |
0.0299 |
0.198 |
Platelet activation |
124 |
17.1 |
25 |
25 |
0.0305 |
0.198 |
Vasopressin-regulated water reabsorption |
44 |
6.07 |
11 |
11 |
0.033 |
0.21 |
Amoebiasis |
96 |
13.2 |
20 |
20 |
0.0363 |
0.226 |
Viral carcinogenesis |
201 |
27.7 |
37 |
37 |
0.0381 |
0.226 |
Regulation of actin cytoskeleton |
214 |
29.5 |
39 |
39 |
0.039 |
0.226 |
Fc gamma R-mediated phagocytosis |
91 |
12.5 |
19 |
19 |
0.0398 |
0.226 |
Hematopoietic cell lineage |
97 |
13.4 |
20 |
20 |
0.04 |
0.226 |
Ferroptosis |
40 |
5.52 |
10 |
10 |
0.0411 |
0.226 |
Fc epsilon RI signaling pathway |
68 |
9.38 |
15 |
15 |
0.0413 |
0.226 |
Staphylococcus aureus infection |
68 |
9.38 |
15 |
15 |
0.0413 |
0.226 |
Autophagy - animal |
128 |
17.7 |
25 |
25 |
0.043 |
0.232 |
Toll-like receptor signaling pathway |
104 |
14.3 |
21 |
21 |
0.044 |
0.233 |
Pancreatic cancer |
75 |
10.3 |
16 |
16 |
0.0472 |
0.242 |
Tuberculosis |
179 |
24.7 |
33 |
33 |
0.0472 |
0.242 |